RecruitingNCT05480644
Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
Sponsor
Duke University
Enrollment
300 participants
Start Date
Dec 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is collecting blood samples from adults with primary brain tumors or cancers that have spread to the brain (brain metastases). Researchers will look for biological markers — small signals in the blood — that could one day be used to diagnose or monitor brain tumors without invasive procedures.
**You may be eligible if...**
- You are an adult with a confirmed diagnosis of a primary brain tumor or a cancer that has spread to the brain (either confirmed by biopsy/pathology or by imaging)
**You may NOT be eligible if...**
- There are no specific exclusion criteria listed for this study
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05480644
Related Trials
Preoperative vs Postoperative Hypofractionated Radiosurgery for Patients With Large Brain Metastases
NCT055450079 locations
Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
NCT046890481 location
Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction
NCT071321901 location
Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases
NCT071307861 location
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
NCT055598531 location